Literature DB >> 8598109

Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature.

S M Marcovina1, H H Hobbs, J J Albers.   

Abstract

The size of apolipoprotein(a) [apo(a)] varies from 187 to 648 kDa because of interallelic differences in the number of kringle 4-encoding sequences in the apo(a) gene. Plasma apo(a) isoform sizes were determined by a high-resolution sodium dodecyl sulfate-agarose gel electrophoretic method, followed by immunoblotting. The relation between the number of apo(a) kringle 4-encoding sequences in the apo(a) gene, as assessed by pulsed-field gel electrophoresis and genomic blotting, and the mobility of apo(a) isoforms in agarose gel was evaluated in 29 individuals who had 48 expressed apo(a) isoforms that contained between 12 and 41 kringle 4 repeats. The log of the kringle number was linearly related to the distance the isoform migrated on the agarose gel (r= 0.999). A nomenclature is proposed to designate apo(a) isoforms by the respective number of kringle 4 repeats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598109

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  31 in total

Review 1.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

Review 2.  Lipoprotein (a) measurements for clinical application.

Authors:  Santica M Marcovina; John J Albers
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

Review 3.  Update on lipoprotein(a) as a cardiovascular risk factor and mediator.

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

4.  Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q.

Authors:  Carole Ober; Alex S Nord; Emma E Thompson; Lin Pan; Zheng Tan; Darren Cusanovich; Ying Sun; Raluca Nicolae; Celina Edelstein; Daniel H Schneider; Christine Billstrand; Ditta Pfaffinger; Natasha Phillips; Rebecca L Anderson; Binu Philips; Ramakrishnan Rajagopalan; Thomas S Hatsukami; Mark J Rieder; Patrick J Heagerty; Deborah A Nickerson; Mark Abney; Santica Marcovina; Gail P Jarvik; Angelo M Scanu; Dan L Nicolae
Journal:  J Lipid Res       Date:  2009-01-05       Impact factor: 5.922

Review 5.  Screening for and management of elevated Lp(a).

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

Review 6.  ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.

Authors:  A F Winder; W Richmond; D T Vallance
Journal:  J Clin Pathol       Date:  1997-09       Impact factor: 3.411

7.  Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients.

Authors:  Marian C Cheung; John J Albers; Hal Kennedy; Hiroshi Deguchi; Darlene J Elias; Patricia M Averell; John H Griffin; Santica M Marcovina
Journal:  Clin Chim Acta       Date:  2010-05-19       Impact factor: 3.786

8.  Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults.

Authors:  Azadeh Beheshtian; Sanyog G Shitole; Alan Z Segal; Dana Leifer; Russell P Tracy; Daniel J Rader; Richard B Devereux; Jorge R Kizer
Journal:  Atherosclerosis       Date:  2016-08-20       Impact factor: 5.162

9.  Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).

Authors:  Margaret R Diffenderfer; Stefania Lamon-Fava; Santica M Marcovina; P Hugh R Barrett; Julian Lel; Gregory G Dolnikowski; Lars Berglund; Ernst J Schaefer
Journal:  Metabolism       Date:  2015-11-06       Impact factor: 8.694

10.  Lipoprotein(a) level as a predictor of cardiovascular disease and small apoliprotein(a) isoforms in dialysis patients: assay-related differences are important.

Authors:  J Craig Longenecker; Josef Coresh; Michael J Klag; Neil R Powe; Nancy E Fink; Santica M Marcovina
Journal:  Clin Chim Acta       Date:  2008-07-18       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.